Samuel C. Blackman M.D., Ph.D.
Net Worth

Last updated:

What is Samuel C. Blackman M.D., Ph.D. net worth?

The estimated net worth of Dr. Samuel C. Blackman M.D., Ph.D. is at least $15,576,973 as of 10 Dec 2024. He owns shares worth $7,041,642 as insider, has earned $6,626,931 from insider trading and has received compensation worth at least $1,908,400 in Day One Biopharmaceuticals, Inc..

What is the salary of Samuel C. Blackman M.D., Ph.D.?

Dr. Samuel C. Blackman M.D., Ph.D. salary is $477,100 per year as Co-Founder & Chief Medical Officer in Day One Biopharmaceuticals, Inc..

How old is Samuel C. Blackman M.D., Ph.D.?

Dr. Samuel C. Blackman M.D., Ph.D. is 56 years old, born in 1969.

What stocks does Samuel C. Blackman M.D., Ph.D. currently own?

As insider, Dr. Samuel C. Blackman M.D., Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Day One Biopharmaceuticals, Inc. (DAWN) Co-Founder & Chief Medical Officer 1,034,015 $6.81 $7,041,642

What does Day One Biopharmaceuticals, Inc. do?

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.

DAWN logo
DAWN
Day One Biopharmaceuticals, Inc.
$6.81

Samuel C. Blackman M.D., Ph.D. insider trading

Day One Biopharmaceuticals, Inc.

Dr. Samuel C. Blackman M.D., Ph.D. has made 42 insider trades between 2021-2024, according to the Form 4 filled with the SEC. Most recently he sold 30,000 units of DAWN stock worth $399,330 on 10 Dec 2024.

The largest trade he's ever made was exercising 50,000 units of DAWN stock on 15 Jun 2022. As of 10 Dec 2024 he still owns at least 1,034,015 units of DAWN stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 30,000 $13.31 $399,330
Sale
Common Stock 2,206 $13.21 $29,141
Option
Common Stock 1,437 N/A N/A
Option
Restricted Stock Unit (RSU) 1,437 N/A N/A
Option
Restricted Stock Unit (RSU) 1,187 N/A N/A
Option
Common Stock 6,062 N/A N/A
Option
Restricted Stock Unit (RSU) 6,062 N/A N/A
Option
Common Stock 1,187 N/A N/A
Sale
Common Stock 10,000 $16.1 $160,990
Sale
Common Stock 18,255 $16.17 $295,238
Sale
Common Stock 11,245 $16.03 $180,291
Sale
Common Stock 500 $16.02 $8,010
Sale
Common Stock 30,000 $14.22 $426,690
Sale
Common Stock 2,232 $14 $31,246
Option
Restricted Stock Unit (RSU) 1,187 N/A N/A
Option
Restricted Stock Unit (RSU) 6,062 N/A N/A
Option
Common Stock 6,062 N/A N/A
Option
Common Stock 1,437 N/A N/A
Option
Restricted Stock Unit (RSU) 1,437 N/A N/A
Option
Common Stock 1,187 N/A N/A
Sale
Common Stock 20,000 $16.01 $320,220
Sale
Common Stock 30,000 $12.62 $378,600
Sale
Common Stock 2,267 $16.08 $36,451
Option
Restricted Stock Unit (RSU) 1,187 N/A N/A
Option
Restricted Stock Unit (RSU) 1,437 N/A N/A
Option
Common Stock 1,187 N/A N/A
Option
Common Stock 1,437 N/A N/A
Option
Common Stock 6,062 N/A N/A
Option
Restricted Stock Unit (RSU) 6,062 N/A N/A
Sale
Common Stock 10,000 $16.37 $163,740
Sale
Common Stock 10,000 $16.02 $160,160
Sale
Common Stock 10,000 $16.01 $160,060
Sale
Common Stock 30,000 $15.24 $457,320
Sale
Common Stock 20,000 $16.11 $322,160
Sale
Common Stock 2,258 $15.25 $34,430
Option
Common Stock 1,187 N/A N/A
Option
Restricted Stock Unit (RSU) 1,187 N/A N/A
Option
Restricted Stock Unit (RSU) 1,437 N/A N/A
Option
Restricted Stock Unit (RSU) 6,062 N/A N/A
Option
Common Stock 1,437 N/A N/A
Option
Common Stock 6,062 N/A N/A
Sale
Common Stock 709 $11.69 $8,288
Option
Common Stock 1,437 N/A N/A
Option
Common Stock 1,187 N/A N/A
Option
Restricted Stock Units 1,437 N/A N/A
Option
Restricted Stock Units 1,187 N/A N/A
Sale
Common Stock 668 $13.86 $9,258
Option
Common Stock 1,187 N/A N/A
Option
Restricted Stock Units 1,187 N/A N/A
Option
Restricted Stock Units 1,437 N/A N/A
Option
Common Stock 1,437 N/A N/A
Sale
Common Stock 1,229 $16 $19,664
Sale
Common Stock 692 $13.12 $9,080
Option
Common Stock 1,437 N/A N/A
Option
Restricted Stock Units 1,187 N/A N/A
Option
Restricted Stock Units 1,437 N/A N/A
Option
Common Stock 1,187 N/A N/A
Sale
Common Stock 10,000 $18.05 $180,480
Sale
Common Stock 674 $19.57 $13,192
Option
Common Stock 1,187 N/A N/A
Option
Restricted Stock Units 1,437 N/A N/A
Option
Restricted Stock Units 1,187 N/A N/A
Option
Common Stock 1,437 N/A N/A
Sale
Common Stock 10,000 $20.07 $200,660
Sale
Common Stock 7,500 $22.75 $170,633
Sale
Common Stock 2,500 $23.21 $58,012
Sale
Common Stock 900 $22.16 $19,940
Sale
Common Stock 9,100 $21.38 $194,594
Sale
Common Stock 377 $21.46 $8,090
Option
Restricted Stock Units 1,187 N/A N/A
Option
Common Stock 1,187 N/A N/A
Sale
Common Stock 10,000 $20.01 $200,050
Sale
Common Stock 10,000 $19.99 $199,850
Sale
Common Stock 8,411 $23.14 $194,647
Sale
Common Stock 1,589 $23.79 $37,809
Sale
Common Stock 941 $24.31 $22,876
Option
Restricted Stock Units 3,561 N/A N/A
Option
Common Stock 3,561 N/A N/A
Sale
Common Stock 10,000 $16.88 $168,810
Sale
Common Stock 867 $19.95 $17,297
Sale
Common Stock 3,309 $19.23 $63,625
Sale
Common Stock 5,824 $18.24 $106,236
Sale
Common Stock 50,000 $16.26 $813,150
Sale
Common Stock 3,328 $17.41 $57,944
Sale
Common Stock 6,672 $16.95 $113,077
Sale
Common Stock 10,000 $17.56 $175,590

Day One Biopharmaceuticals key executives

Day One Biopharmaceuticals, Inc. executives and other stock owners filed with the SEC:

  • Dr. Jeremy Bender M.B.A., Ph.D. (53) Chief Executive Officer, Pres & Director
  • Dr. Samuel C. Blackman M.D., Ph.D. (56) Co-Founder & Chief Medical Officer
  • Ms. Julie Papanek Grant M.B.A. (43) Co-Founder & Chair of the Board